Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study
| Autor: | Aryanian, Zeinab, Balighi, Kamran, Daneshpazhooh, Maryam, Karamshahi, Emad, Hatami, Parvaneh, Goodarzi, Azadeh, Tajalli, Mahroo, Vance, Terrence M. |
|---|---|
| Zdroj: | In International Immunopharmacology July 2021 96 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect